Global network marketing company that develops science-based wellness products aimed at supporting the body's stem cell physiology, marketed and sold internationally through independent distributors and corporate subsidiaries.

# Stemtech Corporation

## Business model and core focus
- Global network marketing company that develops science-based wellness products to support the body's stem cell physiology.
- Marketed as the "Stem Cell Nutrition Company." Products are designed to support stem cell activity by promoting stem cell release, aiding circulation in the blood, and supporting migration into tissues for renewal and health.
- Products are sold internationally through a network of independent distributors and corporate subsidiaries.

## Product brands and lines
- Core brands:
  - RCM System
  - stemrelease3
  - StemFlo
  - MigraStem
  - OraStem (Oral Health Care)
- Skincare products introduced:
  - Cellect One Rapid Renew Stem Cell Peptide Night Cream (launched December 2022)
  - Cellect One Shield HOCL (Hypochlorous Acid) skin care product (introduced January 2025)

## Corporate structure and history
- Incorporated in Nevada as Globe Net Wireless Corp. (ticker: GNTW) on September 4, 2009.
- Rebranded as Stemtech Corporation in Nevada in August 2021.
- On August 19, 2021, Stemtech Corporation (Delaware) completed a reverse merger with Globe Net Wireless Corp. The merger is accounted for as a reverse acquisition and recapitalization under ASC 805; Stemtech (Delaware) is the accounting acquirer for financial reporting purposes.
- Fiscal year end changed from August to December on November 9, 2021.

## Market presence and listing
- Listed on the OTCQB market under the symbol STEK in April 2021.

## Subsidiaries
1. Stemtech HealthSciences Corp (U.S.A.)  
2. Stemtech IP Holdings, LLC (U.S.A.)  
3. Stemtech Canada, Inc. (Canada)  
4. Stemtech Health Sciences S. de R.L. de C.V. (Mexico) — Non-Trading  
5. Stemtech Services SARL de C.V. (Mexico) (Stemtech Mexico) — Non-Trading  
6. Tecrecel Mexico SA de CV (TME)  
7. Stemtech Malaysia Holdings Sdn. Bhd. (Malaysia Holdings) — Non-Trading  
8. Stemtech Malaysia Sdn. Bhd. (Malaysia) — Non-Trading  
9. Stemtech Taiwan Holding, Inc. (Taiwan) — Non-Trading  
10. Stemtech Taiwan Branch  
11. Tecrecel S.A. (Ecuador) — Non-Trading  
12. Food & Health Tech Foodhealth SA (FHT Ecuador) — Non-Trading  
13. Life Factor Research (LFR)

## Cybersecurity and risk management
- Uses SOC 1 Type 2-compliant third-party software for accounting, billing, and payroll.
- Conducts an annual cybersecurity risk review and updates policies accordingly.
- Governance and oversight provided by the President/COO and CEO, with assistance from an outside consultant on risk assessment.
- Controls include MFA/2FA, external email banners, and planned access control lists (ACLs); the company intends to enforce MFA across all platforms by 2025.
- The company is evaluating cyber liability insurance and did not carry such coverage as of the filing.

## Legal proceedings and contingencies
- A 2019 lawsuit by the former CEO against Stemtech Health Sciences Corp. for unpaid salary and vacation pay is ongoing. The company has accrued $267,000 related to this matter as of December 31, 2025. The former CEO’s summary judgment request was dismissed in March 2023, and litigation continues.
- The company is in default under certain Merchant Cash Advance (MCA) financing agreements; those balances remain reflected as liabilities.

Stemtech Corporation is a global network marketing company focused on science-based wellness products, particularly those supporting stem cell health through natural botanicals.

# Company Summary: Stemtech Corporation

## Business Overview
- **Type of Business:**  
  Global network marketing company focused on developing science-based wellness products, particularly related to stem cell science.

- **Core Product Focus:**  
  Supports wellness by helping the body maintain healthy stem cell physiology through stem cell enhancers. These products aim to:
  - Release the body’s own stem cells
  - Promote circulation of stem cells in the blood
  - Facilitate migration of stem cells into tissues for renewal and repair

- **Product Attributes:**  
  - Products are all-natural, plant-based botanicals.
  - Do not contain actual stem cells but support their natural function.
  - Marketed as Stem Cell Nutrition™, with products like the RCM System, stemrelease3™, StemFlo®, MigraStem®, OraStem®, and skincare lines like Cellect One® Night Cream and Shield HOCL.

- **Market & Distribution:**  
  - Marketed internationally via subsidiaries and independent distributors.
  - Primary channels include an independent distributor (IBP) network and direct-to-consumer (DTC) retail model.
  - Plans to expand with new products like StemPets™ for pets, targeting the $303 billion global pet industry.

## Financial and Operational Details
- **Employees & Customers:**  
  Specific number of employees and customers not provided.

- **Revenue & Income:**  
  - **2024 Revenue:** Approximately **$5,053,690**  
  - **2023 Revenue:** Approximately **$4,921,531**  
  - **2024 Net Loss:** **$3,772,701** (improved from $5,431,979 in 2023)  
  - **2023 Net Loss:** **$5,431,979**

- **Additional Business Information:**  
  - The company emphasizes expanding its independent distributor network, projecting the addition of 30,000 new IBPs over 12-24 months.
  - Operates on a network marketing model combining international subsidiaries, independent distributors, and direct-to-consumer sales.
  - The company has been recognized four times in the Inc 5000 list of fastest-growing companies.

## Regulatory & Corporate Details
- **Legal & Regulatory:**  
  - Noted ongoing legal proceedings related to unpaid salary claims.
  - The company is a Nevada-incorporated entity, with a fiscal year-end changed to December 31, as of November 2021.
  - Market trading symbol: **STEK** (OTCQB market).
  - Total shares outstanding as of June 30, 2025: **142,443,444** shares.

## Strategic Focus
- Reinforce product offerings and expand the distributor network.
- Introduce new products to increase market penetration, including pet and skincare lines.
- Aspire to grow revenues and move toward profitability while managing substantial net losses and a significant accumulated deficit.
- Focus on global expansion and leveraging a flexible, network-driven distribution strategy.

Stemtech Corporation is a global network marketing firm specializing in science-based health and wellness products aimed at enhancing the body's stem cell physiology.

# Stemtech Corporation

## Company overview
Stemtech Corporation is a network marketing firm that develops science-based health and wellness products aimed at supporting adult stem cell physiology. The company operates under the brand The Stem Cell Nutrition Company® and focuses on products that promote natural renewal processes of adult stem cells.

## Key products
- RCM System  
- stemrelease3™  
- StemFlo®  
- MigraStem®  
- OraStem® (oral health care)  
- Cellect One® Rapid Renew Stem Cell Peptide Night Cream (introduced December 2022)

## Business structure
- Corporate status: Incorporated in Nevada on September 4, 2009; originally named Globe Net Wireless Corp. The corporate name changed to Stemtech Corporation in August 2021.  
- Market listing: Traded on the OTCQB under the symbol STEK since April 2021.  
- Subsidiaries: Operates through 12 subsidiaries in multiple countries, including the U.S., Canada, Mexico, Malaysia, Taiwan, and Ecuador.

## Market and distribution
- Distribution model: Products are distributed internationally through independent distributors using a network marketing model.  
- Global reach: Markets wellness products across multiple countries, supported by its subsidiary network.

## Financial highlights
- Lease expenses: $73,309 for the year ended December 31, 2023, and $85,629 for the year ended December 31, 2022.

## Legal and financial status
- Legal matter: A former CEO has alleged unpaid salary of $267,000; the company has countered and recorded the related amounts in liabilities on its balance sheet.  
- Cybersecurity: As of the reporting date, no cybersecurity incidents have materially affected operations. The company recognizes potential cybersecurity risks.

## Corporate governance and security
- Cybersecurity and risk oversight: The company maintains cybersecurity protocols to protect sensitive data. Risk assessment and related activities are led by the President & COO and CEO, with support from outside consultants.

## Mission
Stemtech aims to enhance wellness and foster global prosperity through its product offerings and distribution model.

Stemtech Corp

10-K / May 29, 2026

10-K / June 30, 2025

10-K / July 10, 2024

10-K / May 29, 2026

Stemtech Corporation

Business model and core focus

Product brands and lines

Corporate structure and history

Market presence and listing

Subsidiaries

Cybersecurity and risk management

Legal proceedings and contingencies